EquityFlowCompanies › Rapidemic

Rapidemic

Healthtech · Leiden, NL

Azienda olandese di diagnostica molecolare con piattaforma di test per malattie infettive utilizzabile a temperatura ambiente senza elettricita.

Funding history

DateRoundAmount
Sep 2025Grant
Rapidemic received a $2.7 million grant from the Gates Foundation to develop its molecular diagnostics platform for sexually transmitted infections.
$2.7M

Investors

Gates Foundation

Similar companies in Healthtech

Explore funding flow on EquityFlow →